Heather Condley
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,515 of the $3,395 with a category attached, or 74.1%. 25 manufacturers reported payments, led by Biohaven Pharmaceuticals, Inc. at 24.7% of the total. Reporting peaked in 2021 at $1,164 and has fallen 77.3% since, to $264 in 2025. Among family clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 197 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$837
- AbbVie$827
- Lilly USA, LLC$322
- Pfizer$227
- Novo Nordisk$199
- Biohaven Pharmaceutical Holding Company Ltd.$175
- plus $808 from 19 others
What the payments were for
- Consulting fees$80024%
- Food & beverage$2,51574%
- Education$802%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 3 | $837 |
| AbbVie | 46 | $827 |
| Lilly USA, LLC | 28 | $322 |
| Pfizer | 35 | $227 |
| Novo Nordisk | 16 | $199 |
| Biohaven Pharmaceutical Holding Company Ltd. | 15 | $175 |
| Sanofi-aventis U.S. LLC | 9 | $150 |
| Organon | 17 | $106 |
| Seagen Inc. | 1 | $80 |
| Merck | 4 | $66 |
| Astellas Pharma US Inc | 3 | $49 |
| Boehringer Ingelheim | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Sanofi Pasteur Inc. | 2 | $34 |
| Amgen | 2 | $34 |
| Boston Scientific | 1 | $33 |
| AstraZeneca | 2 | $28 |
| Genmab U.S., Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $16 |
| Seqirus USA Inc | 1 | $15 |
| Exact Sciences | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$800
How this compares
$3,395 in reported general payments places this provider in the 90th percentile of 1,460 family providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atovaquone-Proguanil HclAtovaquone/Proguanil Hcl | 46 | $2,785 |
| Levothyroxine Sodium | 47 | $661 |
| Atorvastatin Calcium | 32 | $586 |
| Pantoprazole Sodium | 12 | $312 |
| Omeprazole | 13 | $301 |
| Metformin Hcl | 13 | $122 |
Paid to pharmacies, not to this prescriber.
Other family in Lehi
- Scott LeathamLehi$14K
- Riley WorthSandy$1.1M
- Katrina BawdenSalt Lake City$395K
- Cortnee RomanSalt Lake City$374K
- Jared ThorleySalt Lake City$368K
- Stephanie GodfreyLindon$358K
- Mary SteinbackSalt Lake City$189K
- Shannon FordSouth Jordan$186K
- Jennalyn MayeuxSalt Lake City$151K
- Brett RawlinsKaysville$149K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.